Alyeska Investment Group’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,667
Closed -$700K 485
2023
Q1
$700K Buy
+1,667
New +$700K 0.01% 384